What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Cell biology, Cell adhesion molecule, Immunology, Blood–brain barrier and ICAM-1.
John Greenwood has researched Cell biology in several fields, including Adherens junction and VE-cadherin.
His studies in Cell adhesion molecule integrate themes in fields like T cell and Intercellular adhesion molecule.
Proinflammatory cytokine, Pathogenesis, Autoimmune disease and Protein prenylation is closely connected to HMG-CoA reductase in his research, which is encompassed under the umbrella topic of Immunology.
John Greenwood works mostly in the field of Blood–brain barrier, limiting it down to topics relating to Endothelial stem cell and, in certain cases, Endothelium.
John Greenwood has included themes like Intercellular Adhesion Molecule-1, Neuroinflammation and Molecular biology in his ICAM-1 study.
His most cited work include:
- Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line (951 citations)
- Statin therapy and autoimmune disease: from protein prenylation to immunomodulation (494 citations)
- Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier (286 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Cell biology, Retinal, Blood–brain barrier, Immunology and Internal medicine.
The concepts of his Cell biology study are interwoven with issues in Endothelial stem cell and Retinal pigment epithelium.
His research investigates the connection between Endothelial stem cell and topics such as Endothelium that intersect with issues in Molecular biology.
His study in Retinal is interdisciplinary in nature, drawing from both Blood–retinal barrier, Cell culture, Antigen, Pathology and Retina.
His Blood–brain barrier research is multidisciplinary, incorporating elements of Biochemistry, Mannitol, Thiamine, Perfusion and Vascular permeability.
His ICAM-1 research incorporates elements of Neuroinflammation, Signal transduction and Cell adhesion.
He most often published in these fields:
- Cell biology (37.24%)
- Retinal (21.34%)
- Blood–brain barrier (21.34%)
What were the highlights of his more recent work (between 2011-2021)?
- Cell biology (37.24%)
- Internal medicine (13.81%)
- LRG1 (3.35%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cell biology, Internal medicine, LRG1, Cancer research and Immunology.
John Greenwood has included themes like Retinal pigment epithelium, Retinal, Endothelium and Phenotype in his Cell biology study.
His Retinal research incorporates themes from Pathology, Basement membrane, Molecular biology, Knockout mouse and Endothelial glycocalyx.
The study incorporates disciplines such as Transforming growth factor, Disease, Dysfunctional family and Bioinformatics in addition to LRG1.
His research in Cancer research focuses on subjects like Cancer, which are connected to Endothelial stem cell.
As part of one scientific family, John Greenwood deals mainly with the area of Immunology, narrowing it down to issues related to the Blood vessel, and often Blockade.
Between 2011 and 2021, his most popular works were:
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. (259 citations)
- LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling (215 citations)
- Probing the biomechanical contribution of the endothelium to lymphocyte migration: diapedesis by the path of least resistance (82 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
John Greenwood mostly deals with Cell biology, Immunology, Endothelium, Angiogenesis and Internal medicine.
His studies deal with areas such as Retinal pigment epithelium and Endothelial stem cell as well as Cell biology.
His work carried out in the field of Immunology brings together such families of science as Blood vessel, Vascular endothelial growth factor A, Kinase insert domain receptor and Microcirculation.
John Greenwood has researched Endothelium in several fields, including CCL3, Signal transduction, ICAM-1, Cytoskeleton and Actin.
John Greenwood combines subjects such as Cell junction, Intercellular Adhesion Molecule-1, Immunoglobulin superfamily, Cell adhesion molecule and CD47 with his study of Signal transduction.
His research integrates issues of Cytoprotection, Ex vivo, Process and LRG1 in his study of Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
